Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000916347) titled 'Hydrogen-rich water supplementation for adults with metabolic syndrome' on July 24.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Primary Sponsor: Southern Cross University
Condition:
metabolic syndrome
metabolic syndrome
Metabolic and Endocrine - Metabolic disorders
Intervention:
Hydrogen-rich water, generated by dissolving a hydrogen-generating effervescent tablet (releasing ~4 mg H2) in ~250 mL of room-temperature water, consumed on an empty stomach.
Participants self-administer at home after ins...